Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OTUD6A Inhibitors

The chemical class designated as OTUD6A Inhibitors encompasses a group of compounds characterized by their potential to inhibit the activity of OTUD6A, an OTU deubiquitinase. These inhibitors are primarily focused on modulating the deubiquitinating process in which OTUD6A is involved. The method of inhibition utilized by these compounds is generally based on their ability to interact with the active site of deubiquitinases, thereby impeding the enzymatic action of OTUD6A. This interaction can lead to the disruption of the deubiquitination process, a crucial post-translational modification that regulates protein stability and function. The significance of these inhibitors lies in their potential to modulate the deubiquitination process, which is pivotal in maintaining cellular homeostasis and protein regulation.

Inhibitors in this class are structured to target the catalytic domain of OTUD6A or to interfere with its substrate interaction, resulting in the attenuation of its enzymatic activity. The inhibition process is generally achieved by binding to the active site of OTUD6A, thereby blocking its ability to cleave ubiquitin from substrates. This blockage can lead to an accumulation of ubiquitinated proteins or alter the fate of proteins typically regulated by deubiquitination. The inhibitors are designed to exhibit specificity towards the active site of deubiquitinases, although achieving high specificity is a complex task due to the conserved nature of these active sites among different deubiquitinases. The importance of these inhibitors stems from their role in exploring the regulatory mechanisms of protein ubiquitination and deubiquitination, a process integral to various cellular functions including protein degradation, signal transduction, and DNA damage response. The development and application of OTUD6A inhibitors are crucial for understanding the functional dynamics of OTUD6A in cellular processes. By inhibiting OTUD6A, these compounds provide a means to study the consequences of disrupted deubiquitination on cellular physiology and the role of OTUD6A in these processes. The study of OTUD6A inhibitors also sheds light on the broader implications of deubiquitination in cellular regulation and the potential of targeting specific deubiquitinases for modulating cellular pathways. Through their targeted action, OTUD6A inhibitors contribute to the growing field of research focused on elucidating the complexities of ubiquitin-dependent regulation and the intricate network of protein modifications that dictate cellular behavior and function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PR 619

2645-32-1sc-476324
sc-476324A
sc-476324B
1 mg
5 mg
25 mg
$77.00
$188.00
$431.00
1
(0)

PR-619 is a broad-spectrum deubiquitinase inhibitor and can inhibit OTUD6A by binding to the active sites of various DUBs, including potentially OTUD6A.

WP1130

856243-80-6sc-364650
sc-364650A
10 mg
50 mg
$490.00
$1484.00
1
(0)

WP1130 selectively inhibits several DUBs. It might inhibit OTUD6A by disrupting the deubiquitination process.

Cediranib

288383-20-0sc-483599
sc-483599A
sc-483599B
5 mg
10 mg
25 mg
$137.00
$220.00
$406.00
(0)

HBX 41,108, known to inhibit USP7, could inhibit OTUD6A by binding to the DUB's active site, similar to its action on USP7.

PTP1B Inhibitor

765317-72-4sc-222227
sc-222227A
5 mg
25 mg
$231.00
$936.00
13
(2)

IU1, primarily known to inhibit USP14, could also inhibit OTUD6A by interfering with its deubiquitinating process.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$188.00
$199.00
2
(1)

G5 inhibits multiple DUBs and could potentially inhibit OTUD6A by blocking its active site, preventing deubiquitination.

UCH-L1 Inhibitor Inhibitor

668467-91-2sc-356182
10 mg
$204.00
1
(1)

LDN-57444 inhibits UCH-L1, a DUB enzyme, and might inhibit OTUD6A through a similar mechanism by targeting its active site.